Evidence map›Paper›PMID 40117489›Full record

ReviewMagyar onkologia2025

[Physical therapy of cancer patients - narrative review and expert opinion].

Tamás Bender, Éva Szekanecz, Izabella Gomez, Irén Péntek, Anikó Maráz, Magdolna Dank, Zoltán Szekanecz

Abstract readReviewEnglish Abstract
In one paragraph

Review in Magyar onkologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tamás BenderReumatológiai Osztály, Betegápoló Irgalmasrend, Budai Irgalmasrendi Kórház, Budapest, Hungary. bender.tamas@t-online.hu.
Éva SzekaneczKK, Debreceni Egyetem, Onkológiai Klinika, Debrecen, Hungary.
Izabella GomezOrszágos Mozgásszervi Intézet, Budapest, Hungary.
Irén PéntekÁOK, Semmelweis Egyetem, Belgyógyászati és Onkológiai Klinika, Budapest, Hungary.
Anikó MarázÁOK, Szegedi Tudományegyetem, Onkoterápiás Klinika, Szeged, Hungary.
Magdolna DankÁOK, Semmelweis Egyetem, Belgyógyászati és Onkológiai Klinika, Budapest, Hungary.
Zoltán SzekaneczÁOK, Debreceni Egyetem, Reumatológiai Tanszék, Debrecen, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe issue of physical therapy for people with malignancies has been very controversial. In the past, physical therapy was completely contraindicated in cancer patients. Many doctors are still conservative regarding this issue. Therefore, based on a narrative summary of literature data, we compiled a consensus-based expert opinion.

methodsThe narrative summary was prepared based on publications of the last 5 years. Then the expert group created an expert opinion based on a common consensus.

resultsWe created a concise expert opinion consisting of 10 points and a practical algorithm. The use of physical therapy is established jointly by the patient, doctors and health professionals. Exercise is essentially recommended for everyone. We formulated specific recommendations regarding massage, ultrasound, laser, shockwave, TENS and balneotherapy. These methods can be used with appropriate precautions in cancer patients. On the other hand, most electrotherapy modalities are not recommended, while the evaluation of massage in patients with osteosarcoma is not clear, so we prefer not to recommend it.

conclusionsExercise, certain modalities of physical therapy and balneotherapy can be useful additions to the rehabilitation of cancer patients.

Indexed as

NeoplasmsPhysical Therapy ModalitiesExercise TherapyHumansMassage

Identifiers

PMID40117489
PMCPMC11929575

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.